New pill targets root of asthma inflammation in global trial
NCT ID NCT07191535
Summary
This study is testing an experimental pill called linvemastat as an add-on treatment for adults whose moderate-to-severe asthma isn't fully controlled by their standard inhalers. About 135 participants will take either the new drug or a placebo pill daily for 16 weeks while continuing their usual asthma medications. Researchers will measure if linvemastat improves lung function, reduces asthma attacks, and is safe for patients who need better symptom control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.